Business Wire

IL-RF-IDEAS

6.3.2023 16:31:37 CET | Business Wire | Press release

Share
rf IDEAS Launches End-to-End FIDO2 Credential Solution with IDmelon

rf IDEAS, a leading manufacturer of credential readers for authentication and logical access, is pleased to announce the release of the rf IDEAS FIDO2 Passwordless Platform powered by IDmelon. This end-to-end solution brings seamless, passwordless authentication to existing credentials by converting them to FIDO2 security keys – overnight.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230306005278/en/

FIDO2 frees organizations from password management and risk

Nearly 90% of data breaches are due to stolen passwords or human error. Passwordless single-sign on solutions are helping to combat this challenge, and migrating to more secure credentials helps arm your team with a defense mechanism.

“Partnering with rf IDEAS, and their WAVE ID® technology was a strategic decision for IDmelon – leveraging the trust and reliability of their readers to bring the FIDO2 Passwordless Platform to market allows us to jointly deliver an end-to-end solution that organizations can deploy quickly and scale affordably,” remarked CEO and co-founder of IDmelon Bahram Piri.

The rf IDEAS FIDO2 Passwordless Platform eliminates the need for centrally stored passwords that can be hacked, as well as the risk of password theft, phishing and other user-directed cyberattacks. And for users, it’s simple to roll out and easy to use. Organizations can now enable and manage passwordless authentication across credential types, devices and platforms. This rapidly growing industry standard is supported by Microsoft, Google, Apple, and all leading web services and browsers.

Ushering in a new standard for authentication

The logical access control industry is evolving rapidly to combat cyber threats and data breaches while improving the user experience of authentication without risking governance and security.

“At rf IDEAS, we have listened to our customers and are proud to release a solution that removes the complexities of credential migration, converting users quickly and securely to a higher standard of security,” said Raul Cepeda Jr., Vice President of Product and Marketing at rf IDEAS. “Now, access via security keys is possible using existing credentials, WAVE ID readers, and the rf IDEAS Passwordless Platform – evolving the way we think about migration across credentials by leveraging ID badges and smartphones to unlock potential to more secure authentication methods.”

rf IDEAS and IDmelon will be showcasing their joint solution at the upcoming Gartner IAM symposiums in London and Texas this month – to see a full listing of upcoming events visit our Events Page.

To learn more and set up a 1:1 consultation, visit rfIDEAS.com/FIDO2.

About rf IDEAS

rf IDEAS, Inc. is a leader in logical access solutions for healthcare, manufacturing, financial, government, education and enterprise. The company’s WAVE ID readers are trusted by users across the globe and backed by strong partnerships with leading identity and access management providers. rf IDEAS readers enable innovative solutions for single sign-on, secure printing, and mobile authentication while supporting nearly all credentials worldwide. For more information, visit www.rfIDEAS.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230306005278/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IQM Secures €50M Financing to Accelerate Global Growth30.3.2026 08:00:00 CEST | Press release

€50 million financing package from funds and accounts managed by BlackRock will support IQM to scale operations, accelerate product development, and strengthen its market position. The facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing as IQM prepares for public listing. IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), today announced it has secured a €50 millionfinancing package from funds and accounts managed by BlackRock. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329996942/en/ IQM Radiance quantum computer is located in IQM's showroom in Espoo, Finland. This facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing. This

Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations30.3.2026 07:45:00 CEST | Press release

Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, particularly in regions where regulatory and inspection controls remain stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329411683/en/ Addressing Critical Trade Finance Challenges The agreement comes at a pivotal time for global trade. Letters of Credit (LCs) continue to serve as essential instruments in international commerce, particularly across the Middle East and Africa, where counterparty risk, foreign exchange controls, sanctions exposure, and regulatory oversight face ongoing challenges. In

Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release

~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye